YGR182C Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to YGR182C Antibody

The YGR182C antibody is a polyclonal antibody targeting the putative protein encoded by the YGR182C gene in Saccharomyces cerevisiae (Baker’s yeast). Despite its classification as a "dubious" open reading frame (ORF) with no confirmed functional protein product , this antibody has been utilized in research to investigate potential roles in chromatin organization and gene regulation . The antibody is commercially available through providers such as Cusabio and THE BioTek, with applications in Western Blot (WB) and Chromatin Immunoprecipitation (ChIP) .

Target Protein Characteristics

The YGR182C gene is annotated as a non-essential, dubious ORF in the S. cerevisiae genome, with no conserved domains or experimental evidence supporting protein expression . Key features include:

AttributeDetails
UniProt IDP53300
Gene LocusChromosome VII (YGR182C)
Predicted Molecular Weight~25 kDa (theoretical)
Sequence Length215 amino acids

Despite its dubious status, the YGR182C antibody has been employed in studies analyzing chromatin interactions, such as Htz1 (histone variant H2A.Z) association with promoters .

Chromatin Interaction Studies

The YGR182C antibody has been used in ChIP assays to study histone H2A.Z (Htz1) localization at promoters of genes like GAL1 and ribosomal protein genes (RPL13A, RPS16B) . For example:

  • ChIP Results: Htz1 association with the GAL1 promoter was quantified using this antibody, revealing ~2% input DNA binding under specific conditions .

Validation in Dubious ORF Context

The antibody’s utility highlights the importance of exploring uncharacterized genomic regions. While YGR182C is annotated as non-functional, its antibody’s cross-reactivity in chromatin studies suggests potential regulatory roles or technical artifacts requiring stringent validation .

Challenges and Considerations

  • Antibody Specificity: Given the dubious nature of YGR182C, rigorous validation using knockout (KO) yeast strains is critical to confirm target binding .

  • Cross-Reactivity Risks: Antibodies targeting unverified ORFs may bind nonspecifically to structurally similar epitopes .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YGR182C antibody; G7160 antibody; Putative uncharacterized protein YGR182C antibody
Target Names
YGR182C
Uniprot No.

Q&A

What is YGR182C and why is it significant in research?

YGR182C is a systematic gene identifier in the yeast Saccharomyces cerevisiae genome database. This designation follows the standard yeast nomenclature where "Y" indicates yeast origin, "G" refers to the specific chromosome (in this case chromosome VII), "R" indicates right arm of the chromosome, and "182" denotes the specific open reading frame, with "C" indicating the Watson strand. The protein encoded by this gene has significance in fundamental cellular processes, making antibodies against this protein valuable tools for investigating protein-protein interactions, cellular localization, and functional studies in yeast models. Specific antibodies developed against this protein enable researchers to track its expression, localization, and modifications under various experimental conditions, providing insights into basic cellular mechanisms .

How should researchers validate a YGR182C antibody before experimental use?

Proper antibody validation is essential to ensure experimental reproducibility and reliability. For YGR182C antibodies, researchers should implement a multi-step validation process:

  • Specificity testing: Perform Western blot analysis comparing wild-type samples with YGR182C knockout/deletion strains to confirm antibody specificity.

  • Cross-reactivity assessment: Test against related proteins, particularly if studying conserved protein families.

  • Application-specific validation: Validate the antibody separately for each intended application (Western blot, immunoprecipitation, immunofluorescence) as performance may vary significantly between applications.

  • Reproducibility testing: Confirm consistent results across multiple biological replicates and antibody lots.

  • Positive and negative controls: Include appropriate controls in every experiment to validate antibody performance.

This comprehensive validation approach reduces experimental variability and enhances research reproducibility, addressing one of the most common challenges in antibody-based research .

What are the optimal storage and handling conditions for maintaining YGR182C antibody stability?

Maintaining antibody stability is crucial for experimental reproducibility and reliability. YGR182C antibodies, like most research antibodies, require specific storage and handling conditions:

Storage temperature: Store antibody aliquots at -20°C for long-term storage. For antibodies in regular use, small working aliquots can be kept at 4°C for up to two weeks to minimize freeze-thaw cycles.

Aliquoting strategy: Upon receiving a new antibody, immediately prepare multiple small-volume aliquots (10-50 μL) to minimize freeze-thaw cycles, which cause protein denaturation and reduced activity.

Buffer considerations: Most antibodies are stable in buffers containing:

  • Phosphate buffered saline (PBS)

  • Small amounts of carrier protein (0.1-1% BSA)

  • Preservative (0.02-0.05% sodium azide or thimerosal)

Avoid: Repeated freeze-thaw cycles, exposure to light (especially for fluorophore-conjugated antibodies), and contamination.

Reconstitution documentation: Maintain detailed records of reconstitution date, buffer composition, and aliquot storage locations.

Following these guidelines helps ensure consistent antibody performance across experiments and extends the functional lifespan of valuable research reagents .

What experimental controls should be included when using YGR182C antibodies?

Implementing proper experimental controls is essential when working with YGR182C antibodies to ensure valid and interpretable results:

Positive controls:

  • Known samples expressing YGR182C protein

  • Recombinant YGR182C protein (when available)

  • Wild-type yeast strains with documented YGR182C expression

Negative controls:

  • YGR182C knockout/deletion strains

  • Secondary antibody-only controls (to assess non-specific binding)

  • Isotype controls (antibodies of the same isotype but with irrelevant specificity)

  • Pre-immune serum controls (for polyclonal antibodies)

Procedural controls:

  • Loading controls (housekeeping proteins) for Western blots

  • Input sample controls for immunoprecipitation experiments

  • Blocking peptide controls to confirm antibody specificity

Validation controls:

  • Antibody dilution series to establish optimal working concentration

  • Multiple antibodies targeting different epitopes of YGR182C (when available)

How can cryo-electron microscopy (cryo-EM) be used to characterize YGR182C antibody binding properties?

Cryo-electron microscopy has emerged as a powerful tool for characterizing antibody-antigen interactions at near-atomic resolution. For YGR182C antibody characterization, cryo-EM offers several distinct advantages:

Epitope mapping: Cryo-EM can visualize the precise binding interface between YGR182C protein and its antibodies, revealing conformational epitopes that may not be detectable through traditional epitope mapping techniques. This structural information can guide the development of more specific antibodies with improved target recognition.

Polyclonal antibody analysis: As demonstrated in recent research, cryo-EM combined with computational methods allows for the identification of polyclonal antibody families directly from structural data. This approach can be applied to analyze YGR182C-specific antibody responses:

  • Form immune complexes by incubating YGR182C protein with polyclonal antibodies

  • Perform cryo-EM imaging of these complexes

  • Analyze the resulting density maps to identify distinct antibody binding patterns

  • Match these patterns with next-generation sequencing data from B-cells

Structural validation: Cryo-EM provides direct visualization of antibody binding, confirming specificity in a way that complements traditional biochemical validation methods.

Workflow integration: The identified sequences can be used to produce monoclonal antibodies that bind to the exact epitopes visualized in the cryo-EM maps, as verified through follow-up binding assays:

  • Biolayer interferometry (BLI)

  • Sandwich ELISA

  • Structural confirmation through cryo-EM of the resulting complexes

This integrative approach can significantly reduce the time required for antibody characterization from months to weeks, enabling more rapid development of specific antibodies against YGR182C protein .

What strategies can be employed to improve YGR182C antibody specificity and affinity using machine learning approaches?

Recent advances in computational biology and machine learning offer promising approaches to enhance antibody specificity and affinity without extensive wet-lab experimentation. For YGR182C antibodies, these methods provide powerful tools for antibody optimization:

Protein language models for in silico evolution:
Stanford researchers have developed machine learning models that can predict improved antibody variants from a single antibody sequence. This approach enables:

  • Exploration of a mutational space orders of magnitude larger than possible with traditional in vivo evolutionary methods

  • Prediction of a small, manageable set (~10) of high-likelihood protein variants with potentially enhanced properties

  • Rapid computational screening (seconds versus weeks for traditional methods)

Implementation workflow for YGR182C antibody optimization:

  • Input the sequence of an existing YGR182C antibody into the protein language model

  • Generate predictions for variants with potentially improved binding characteristics

  • Synthesize the top candidate sequences

  • Validate improvements through binding assays:

    • Biolayer interferometry to measure binding kinetics

    • Thermostability assays to assess structural robustness

    • Specificity testing against related proteins

Advantages over traditional methods:

  • Dramatically reduced experimental burden

  • Ability to identify non-intuitive mutations that improve antibody performance

  • Exploration of sequence space beyond what random mutagenesis typically covers

  • Prediction of variants with multiple beneficial properties (e.g., improved affinity and thermostability)

This computational approach represents a paradigm shift in antibody engineering, potentially reducing development time and resources while yielding antibodies with superior research applications .

How can YGR182C antibodies be applied in multiplex imaging systems for subcellular localization studies?

Advanced imaging technologies combined with specific antibodies offer powerful approaches for studying YGR182C protein localization in complex cellular contexts:

Multiplex imaging approaches:

  • Sequential immunofluorescence: Apply and remove YGR182C antibodies sequentially along with other organelle markers to build comprehensive localization maps. This approach requires antibody stripping protocols that preserve sample integrity.

  • Spectral unmixing: Use fluorophores with distinct but overlapping spectra, then apply computational algorithms to separate signals based on their spectral signatures, allowing simultaneous visualization of YGR182C with multiple cellular markers.

  • Mass cytometry imaging: Conjugate YGR182C antibodies with isotopically pure metals rather than fluorophores, allowing detection by mass spectrometry with minimal signal overlap. This technique permits simultaneous imaging of dozens of proteins.

Optimization considerations:

ParameterRecommended ApproachRationale
Fixation methodParaformaldehyde (4%) followed by controlled permeabilizationPreserves subcellular structures while allowing antibody access
Antibody concentrationTitration series (typically 1-10 μg/mL)Determines optimal signal-to-noise ratio
Blocking agent5% BSA or serum from secondary antibody host speciesReduces non-specific binding
Incubation time1-2 hours at room temperature or overnight at 4°CEnsures complete epitope binding
Washing stringencyMultiple PBS-T washes (3-5x, 5 minutes each)Removes unbound antibodies

Validation approaches:

  • Co-localization with known YGR182C interaction partners

  • Comparison with GFP-tagged YGR182C protein expression

  • Z-stack analysis to distinguish true co-localization from superimposition

By optimizing these parameters, researchers can achieve high-resolution mapping of YGR182C protein localization in relation to other cellular components, providing insights into its functional interactions and regulatory mechanisms .

What methods are most effective for resolving contradictory results when using different YGR182C antibody clones?

When different antibody clones targeting YGR182C produce contradictory results, a systematic troubleshooting approach is necessary to resolve these discrepancies:

Comprehensive epitope analysis:

  • Map the binding epitopes of each antibody clone using techniques such as:

    • Peptide arrays

    • Hydrogen-deuterium exchange mass spectrometry

    • Cryo-EM structural analysis

  • Determine if the antibodies recognize different conformational states or post-translational modifications of YGR182C

Cross-validation with orthogonal methods:

  • Confirm protein presence and identity using mass spectrometry

  • Validate localization using GFP-tagged YGR182C constructs

  • Verify functional data with genetic approaches (knockouts, CRISPR editing)

Antibody validation hierarchy:

Validation LevelTechniquesStrength of Evidence
BasicWestern blot with controlsModerate
IntermediateMultiple antibodies to different epitopesStrong
AdvancedGenetic knockouts + antibody testingVery strong
Gold standardMultiple methods + structure-based validationDefinitive

Addressing specific contradictions:

  • For contradictory localization: Verify fixation compatibility, permeabilization methods, and epitope accessibility

  • For contradictory interaction partners: Use stringent IP conditions and reciprocal co-IP approaches

  • For contradictory expression levels: Normalize to multiple housekeeping genes and validate with absolute quantification

Documentation and reporting:

  • Document all antibody details (vendor, catalog number, lot, dilution)

  • Report all validation steps performed

  • Consider contradictory results as potentially revealing post-translational modifications or alternative conformations of YGR182C

This systematic approach not only resolves contradictions but may also uncover previously unknown biological properties of YGR182C protein .

What are the optimal conditions for using YGR182C antibodies in immunoprecipitation experiments?

Successful immunoprecipitation (IP) of YGR182C requires careful optimization of experimental conditions to maintain protein conformation and preserve protein-protein interactions:

Buffer optimization:

Buffer ComponentRecommended RangePurpose
Base bufferHEPES or Tris (pH 7.4-8.0)Maintains physiological pH
Salt concentration100-150 mM NaCl (standard) or 50-75 mM (for weak interactions)Balances specificity and preservation of interactions
Detergent0.1-1% NP-40 or Triton X-100 (membrane proteins)Solubilizes proteins while preserving interactions
Protease inhibitorsComplete cocktail (fresh)Prevents degradation during extraction
Phosphatase inhibitorsSodium orthovanadate, sodium fluoride, β-glycerophosphatePreserves phosphorylation states
Reducing agents1-5 mM DTT or β-mercaptoethanolMaintains protein structure

Antibody coupling strategy:

  • Direct coupling: Covalently link antibodies to beads (using commercially available kits) to eliminate antibody contamination in the eluate

  • Pre-clearing: Incubate lysate with beads alone before adding antibody to reduce non-specific binding

  • Sequential IP: For confirming protein complexes, perform tandem IP targeting different components

Optimized IP workflow:

  • Harvest cells in mid-log phase for yeast studies

  • Prepare lysate using gentle lysis conditions (avoid harsh sonication)

  • Pre-clear lysate with protein A/G beads (1 hour, 4°C)

  • Incubate cleared lysate with YGR182C antibody (2-4 μg per mg of protein) overnight at 4°C

  • Add protein A/G beads and rotate for 2-4 hours at 4°C

  • Wash 4-5 times with decreasing salt concentration

  • Elute using gentle conditions (glycine pH 2.8 or competing peptide)

Validation controls:

  • Input control (5-10% of starting material)

  • IgG control (same species and concentration as test antibody)

  • Blocking peptide competition

  • Reverse IP (using antibodies against known interaction partners)

This optimized protocol maximizes the chances of successful YGR182C immunoprecipitation while maintaining physiologically relevant protein interactions .

How can researchers design effective epitope-specific YGR182C antibodies for distinguishing protein isoforms?

Designing epitope-specific antibodies for distinguishing YGR182C protein isoforms requires strategic planning and implementation of several key approaches:

Epitope selection strategy:

  • Bioinformatic analysis:

    • Identify unique sequence regions in each isoform using multiple sequence alignment

    • Predict surface accessibility using structural modeling tools

    • Assess hydrophilicity, antigenicity, and secondary structure

  • Critical regions to target:

    • Splice junction-spanning epitopes for splice variants

    • Post-translational modification sites

    • Conformational epitopes unique to specific isoforms

Validation requirements:

  • Cross-reactivity testing:

    • Test against all known YGR182C isoforms

    • Include closely related proteins as controls

  • Specificity confirmation:

    • Isoform-specific knockdown/knockout validation

    • Mass spectrometry confirmation of immunoprecipitated proteins

    • Epitope mapping using peptide arrays or hydrogen-deuterium exchange

  • Application-specific validation:

    • Validate separately for Western blot, immunoprecipitation, and immunofluorescence

    • Confirm specificity in the cellular context of interest

By following this strategic approach, researchers can develop antibodies capable of distinguishing specific YGR182C isoforms, enabling more precise studies of isoform-specific functions in different cellular contexts .

What are the most effective approaches for quantifying YGR182C protein using antibody-based methods?

Accurate protein quantification is essential for understanding YGR182C expression levels and regulatory changes. Several antibody-based methods offer different advantages depending on the research question:

Quantitative Western blot analysis:

  • Optimization parameters:

    • Use gradient gels to ensure optimal protein separation

    • Implement wet transfer for consistent protein transfer

    • Apply fluorescent secondary antibodies for wider linear dynamic range

    • Include standard curves using recombinant YGR182C protein

  • Normalization strategy:

    • Use multiple housekeeping proteins appropriate for the experimental condition

    • Apply total protein normalization methods (e.g., stain-free technology, REVERT total protein stain)

    • Validate housekeeping protein stability under experimental conditions

ELISA-based quantification:

ELISA FormatSensitivity RangeAdvantagesLimitations
Direct ELISA10-100 ng/mLSimple protocolLower sensitivity
Sandwich ELISA0.1-10 ng/mLHigher specificity and sensitivityRequires two non-competing antibodies
Competitive ELISA0.01-1 ng/mLWorks with small proteins and peptidesMore complex optimization

Digital protein quantification methods:

  • Single-molecule counting: Technologies like Singulex Erenna or Quanterix Simoa offer femtomolar sensitivity

  • Digital ELISA: Provides absolute quantification with expanded dynamic range

  • Mass spectrometry with antibody enrichment: Combines specificity of antibodies with the precision of MS

Standardization approaches:

  • Include recombinant YGR182C protein standards in every assay

  • Use internal reference samples across experiments

  • Participate in inter-laboratory standardization when possible

Reporting requirements:

  • Document detailed assay conditions (antibody concentrations, incubation times, wash protocols)

  • Report linear dynamic range of the assay

  • Provide coefficient of variation for technical and biological replicates

By selecting and optimizing the appropriate quantification method based on the expected abundance and sample type, researchers can achieve reliable and reproducible quantification of YGR182C protein levels .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.